BAIN CAPITAL INVESTORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001040508

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 8 positions · Total reported value $4.82B · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, BAIN CAPITAL INVESTORS LLC disclosed 8 equity positions with a combined reported value of $4.82B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were BOBS ($1.51B), SGRY ($839.11M), AVAH ($699.32M). By sector, the heaviest allocations are Health Care 57.3%, Consumer Discretionary 31.4%. Versus the prior quarter, allocation shifted toward Health Care (+7.6pp) and away from Consumer Discretionary (-2.9pp), Technology (-4.7pp).

Versus the prior quarter, BAIN CAPITAL INVESTORS LLC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 88% of names.

The largest new positions opened in Q2 2026 were KLRA ($578.41M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • KLRA KAILERA THERAPEUTICS INC · $578.41M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest BAIN CAPITAL INVESTORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-04-20 Buy Kailera Therapeutics, Inc. 8,398,438 $16.00 SEC filing
2026-04-20 Conversion Kailera Therapeutics, Inc. 17,857,143 — SEC filing

All insider transactions →

Fund Profile

Bain Capital Investors files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 8 positions worth $4.82B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 8 positions · $4.82B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: BOBS (BOBS DISC FURNITURE INC) at 31.3%
  • Average position size: $601.97M

Sector Tilt

  • Health Care 57.3%
  • Consumer Discretionary 31.4%
  • Information Technology 11.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: BAIN CAPITAL INVESTORS LLC maintained a conservative stance in the second quarter of 2026, with no significant changes in positions or weightings. The fund's actions are primarily "Hold," suggesting a wait-and-see approach to market movements. 2. Key Moves: - Added: Kailera Therapeutics (KLRA) as a new holding in the Health Care sector. - No Change: Remaining positions were held steady, with no additions or reductions in shares. - No Reductions: No holdings were reduced or sold during the quarter. 3. Portfolio Structure: - Passive vs. Active: The portfolio seems to lean towards passive management, as there were no significant changes in holdings. - Sector Bias: The Health Care sector is the most heavily represented, with three out of the top five holdings. - Risk Appetite: The fund's risk appetite appears moderate, given the lack of significant changes in holdings and sectors. 4. Per-Holding One-Liner: - BOBS (BOBS DISC FURNITURE): A company specializing in discount furniture. - SGRY (SURGERY PARTNERS INC COM): A provider of surgical services and facilities. - AVAH (AVEANNA HEALTHCARE HLDGS INC): A biopharmaceutical company focused on developing treatments for various diseases. - KMTS (KESTRA MED TECHNOLOGIE F): A medical technology company. - KLRA (KAILERA THERAPEUTICS INC): A biotechnology company developing therapies for various conditions. - NTNX (NUTANIX INC): A provider of cloud computing software and services. - WAY (WAYSTAR HLDG CORP): A holding company with investments in technology and healthcare. - ADV (ADVANTAGE SOLUTIONS INC): A company that provides solutions for the home improvement industry. - Unverified: None provided. 5. One-Sentence Style Summary: BAIN CAPITAL INVESTORS LLC held steady in Q2 2026, maintaining a conservative approach with a focus on the Health Care sector and minimal changes in its holdings.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 57.3%
Technology 11.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 95.37M $1.51B 31.33%
31.33%
Hold
2 49.95M $839.11M 17.42%
17.42%
Hold
3 81.60M $699.32M 14.52%
14.52%
Hold
4 25.17M $640.38M 13.30%
13.30%
Hold
5 26.26M $578.41M 12.01%
12.01%
New
6 5.36M $272.91M 5.67%
5.67%
Hold
7 13.24M $271.89M 5.65%
5.65%
Hold
8 115.60K $5.00M 0.10%
0.10%
Hold

FAQ

What did BAIN CAPITAL INVESTORS LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, BAIN CAPITAL INVESTORS LLC reported 8 equity positions worth $4.82B in aggregate; its largest disclosed positions were BOBS ($1.51B), SGRY ($839.11M), AVAH ($699.32M).

How large is BAIN CAPITAL INVESTORS LLC's portfolio?

BAIN CAPITAL INVESTORS LLC reported $4.82B of long equity holdings across 8 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is BAIN CAPITAL INVESTORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bain-capital-investors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →